VALIDATION OF A 46-GENE CELL CYCLE PROGRESSION (CCP) RNA SIGNATURE FOR PREDICTING PROSTATE CANCER DEATH IN A CONSERVATIVELY MANAGED WATCHFUL WAITING NEEDLE BIOPSY COHORT

被引：2

作者：

Cuzick, Jack

Stone, Steven

Yang, Zi Hua

Reid, Julia

Fisher, Gabrielle

Berney, Daniel

Beltran, Luis

Moller, Henrik

Greenberg, David

Brawer, Michael

Gutin, Alexander

Lanchbury, Jerry

Scardino, Peter

机构：

来源：

JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期

关键词：

D O I：

10.1016/j.juro.2014.02.2520

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

MP79-17

引用

页码：E936 / E936

页数：1

共 9 条

[1] Prognostic value of a 46-gene cell cycle progression (CCP) RNA signature for prostate cancer death in a conservatively managed watchful waiting needle biopsy cohort
Cuzick, J. M.
Fisher, G.
Berney, D.
Mesher, D.
Moller, H.
Reid, J. E.
Gutin, A.
Lanchbury, J. S.
Stone, S.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[2] Validation of an RNA cell cycle progression (CCP) score for predicting prostate cancer death in a conservatively managed needle biopsy cohort.
Cuzick, Jack M.
Stone, Steven
Fisher, Gabrielle
Yang, Zi Hua
North, Bernard
Berney, Daniel
Beltran, Luis
Greenberg, David
Meller, Henrik
Reid, Julia E.
Gutin, Alexander
Lanchbury, Jerry S.
Brawer, Michael K.
Scardino, Peter T.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[3] Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
J Cuzick
S Stone
G Fisher
Z H Yang
B V North
D M Berney
L Beltran
D Greenberg
H Møller
J E Reid
A Gutin
J S Lanchbury
M Brawer
P Scardino
British Journal of Cancer, 2015, 113 : 382 - 389
[4] Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
Cuzick, J.
Stone, S.
Fisher, G.
Yang, Z. H.
North, B. V.
Berney, D. M.
Beltran, L.
Greenberg, D.
Moller, H.
Reid, J. E.
Gutin, A.
Lanchbury, J. S.
Brawer, M.
Scardino, P.
BRITISH JOURNAL OF CANCER, 2015, 113 (03) : 382 - 389
[5] Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
J Cuzick
D M Berney
G Fisher
D Mesher
H Møller
J E Reid
M Perry
J Park
A Younus
A Gutin
C S Foster
P Scardino
J S Lanchbury
S Stone
British Journal of Cancer, 2012, 106 : 1095 - 1099
[6] Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
Cuzick, J.
Berney, D. M.
Fisher, G.
Mesher, D.
Moller, H.
Reid, J. E.
Perry, M.
Park, J.
Younus, A.
Gutin, A.
Foster, C. S.
Scardino, P.
Lanchbury, J. S.
Stone, S.
BRITISH JOURNAL OF CANCER, 2012, 106 (06) : 1095 - 1099
[7] Re: Validation of an RNA Cell Cycle Progression Score for Predicting Death from Prostate Cancer in a Conservatively Managed Needle Biopsy Cohort Editorial Comment
Cuzick, J.
Stone, S.
Fisher, G.
Yang, Z. H.
North, B. V.
Berney, D. M.
Beltran, L.
Greenberg, D.
Moller, H.
Reid, J. E.
Gutin, A.
Lanchbury, J. S.
Brawer, M.
Scardino, P.
JOURNAL OF UROLOGY, 2016, 195 (06): : 1779 - 1780
[8] Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort
Mucci, Lorelei A.
Pawitan, Yudi
Demichelis, Francesca
Fall, Katja
Stark, Jennifer R.
Adami, Hans-Olov
Andersson, Swen-Olof
Andren, Ove
Eisenstein, Anna S.
Holmberg, Lars
Huang, Wei
Kantoff, Philip W.
Perner, Sven
Stampfer, Meir J.
Johansson, Jan-Erik
Rubin, Mark A.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (01) : 249 - 251
[9] Development and validation of a mutivariate model combining cell cycle progression score with CAPRA to predict prostate cancer mortality in a conservatively managed cohort
Brawer, Michael K.
Cooperberg, Matthew R.
Freedland, Stephen J.
Swanson, Gregory P.
Stone, Steven
Reid, Julia E.
Gutin, Alexander
Carroll, Peter
Cuzick, Jack M.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)

← 1 →